Figure 5
Figure 5. The EGFP-positive cells between the DA and PCV are early hematopoietic cells. (A,B) Lateral views of the trunk of 48 hpf Tg(runx1P2:EGFP)/Tg(gata1:DsRED) double-transgenic embryo confirms the localization of round EGFP-expressing cells between the DA and PCV (arrowheads). (C,E,G,I) Lateral views of the trunk regions of uninjected (uninj) and MO-injected 48 hpf Tg(runx1P2:EGFP) embryos. (D,F,H) Lateral bright-field and (D′,F′,H′) fluorescent images of 48 hpf MO-injected transgenic embryos together with uninjected controls. (D,E) The hematopoietic EGFP-expressing cells are abolished in runx1 runt domain MO-injected embryos (arrowheads). (F,G) Injection of scl MO ablated the EGFP-positive cells between the DA and PCV (arrowheads). (H,I) Injection of gata1 MO increased EGFP expression in the AGM region compared with controls (arrowheads).

The EGFP-positive cells between the DA and PCV are early hematopoietic cells. (A,B) Lateral views of the trunk of 48 hpf Tg(runx1P2:EGFP)/Tg(gata1:DsRED) double-transgenic embryo confirms the localization of round EGFP-expressing cells between the DA and PCV (arrowheads). (C,E,G,I) Lateral views of the trunk regions of uninjected (uninj) and MO-injected 48 hpf Tg(runx1P2:EGFP) embryos. (D,F,H) Lateral bright-field and (D′,F′,H′) fluorescent images of 48 hpf MO-injected transgenic embryos together with uninjected controls. (D,E) The hematopoietic EGFP-expressing cells are abolished in runx1 runt domain MO-injected embryos (arrowheads). (F,G) Injection of scl MO ablated the EGFP-positive cells between the DA and PCV (arrowheads). (H,I) Injection of gata1 MO increased EGFP expression in the AGM region compared with controls (arrowheads).

Close Modal

or Create an Account

Close Modal
Close Modal